Saturday, August 27, 2005

A Damning Admission

From Business Week:

“The shift to drugs tailored to a specific genetic profile will bring massive changes to a pharmaceutical industry long wedded to treatments that can be taken by millions upon millions. Most prescription medicines are now effective for fewer than half of the people who take them -- and the side effects can be worse than the illnesses.

‘From a strategic standpoint, of meeting the needs of our customers, the current blockbuster model doesn't work,’ concedes Sidney Taurel, chairman and CEO of Eli Lilly & Co.”


Post a Comment

<< Home